SKYTROFA® is the first FDA-approved once-weekly pediatric growth hormone treatment that delivers:

Calendar Icon

More injection-free days with once-weekly dosing compared with daily therapies

Not Refridgerated Icon

Convenient storage with no required refrigeration for up to 6 months*

Measuring Ruler Icon

Higher growth rate after 1 year in a clinical trial compared with a daily somatropin therapy